Core Laboratories Inc. (NYSE:CLB – Free Report) – Research analysts at Zacks Research cut their FY2027 EPS estimates for Core Laboratories in a note issued to investors on Friday, July 17th. Zacks Research analyst Team now forecasts that the oil and gas company will post earnings of $0.80 per share for the year, down from their prior forecast of $0.82. The consensus estimate for Core Laboratories’ current full-year earnings is $0.53 per share.
Other research analysts have also issued research reports about the company. Weiss Ratings lowered Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, June 24th. Wall Street Zen downgraded Core Laboratories from a “hold” rating to a “sell” rating in a research report on Saturday, July 4th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Reduce”.
Core Laboratories Stock Down 1.3%
CLB stock opened at $11.20 on Monday. The company has a 50 day moving average price of $12.47 and a two-hundred day moving average price of $15.63. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.50 and a current ratio of 2.05. The stock has a market capitalization of $516.09 million, a P/E ratio of 17.22, a PEG ratio of 2.74 and a beta of 1.00. Core Laboratories has a one year low of $9.72 and a one year high of $20.36.
Core Laboratories (NYSE:CLB – Get Free Report) last announced its quarterly earnings data on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.06. Core Laboratories had a net margin of 5.94% and a return on equity of 11.52%. The business had revenue of $121.80 million for the quarter, compared to the consensus estimate of $122.99 million. During the same quarter in the prior year, the firm posted $0.14 earnings per share. The company’s quarterly revenue was down 1.4% compared to the same quarter last year. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS.
Core Laboratories Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Monday, May 11th were issued a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date was Monday, May 11th. Core Laboratories’s payout ratio is presently 6.15%.
Hedge Funds Weigh In On Core Laboratories
Several institutional investors and hedge funds have recently bought and sold shares of the stock. Summit Securities Group LLC acquired a new position in shares of Core Laboratories in the 1st quarter valued at $31,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of Core Laboratories during the 4th quarter worth $34,000. CWM LLC increased its holdings in shares of Core Laboratories by 36.1% during the 4th quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock worth $40,000 after buying an additional 668 shares during the last quarter. Quarry LP raised its position in shares of Core Laboratories by 118.1% in the 3rd quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock worth $36,000 after buying an additional 1,599 shares during the period. Finally, Hantz Financial Services Inc. raised its position in shares of Core Laboratories by 124.7% in the 4th quarter. Hantz Financial Services Inc. now owns 3,177 shares of the oil and gas company’s stock worth $51,000 after buying an additional 1,763 shares during the period. Institutional investors and hedge funds own 97.81% of the company’s stock.
Core Laboratories Company Profile
Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.
The company’s portfolio spans two primary service lines: reservoir description and production enhancement.
Read More
- Five stocks we like better than Core Laboratories
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
